Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 0.4% – Here’s Why

Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) dropped 0.4% during trading on Friday. The stock traded as low as $0.85 and last traded at $0.85. 991 shares traded hands during trading, a decline of 89% from the average session volume of 9,053 shares. The stock had previously closed at $0.8535.

Peak Pharmaceuticals Trading Down 41.2%

The company has a 50-day moving average price of $0.95 and a two-hundred day moving average price of $1.28.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Stories

• Five stocks we like better than Peak Pharmaceuticals
• Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
• 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
• Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
• Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.